Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.130
-0.100 (-4.48%)
Feb 21, 2025, 4:00 PM EST - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $40.57 million as of February 21, 2025. Its market cap has decreased by -62.62% in one year.
Market Cap
40.57M
Enterprise Value
27.93M
1-Year Change
-62.62%
Ranking
Category
Stock Price
$2.13
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $40.57M, a decrease of -35.10%. That is a compound annual growth rate of -8.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 40.57M | -41.54% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |